The life sciences industry is at an inflection point.  Market disruptions, new technologies, patient expectations, and regulatory shifts are reshaping the way organizations operate and deliver value. Success in this environment requires more than adaptation—it demands bold innovation, smart collaboration, and a relentless focus on patients.

In this keynote, Daniel R. Matlis, President & Founder of Axendia, Inc., will share insights on how innovation and disruption are converging to define the future of life sciences. He’ll explore how organizations can:

• Drive Resilience Through Innovation: Build value networks and adopt smart-shoring strategies to thrive in dynamic markets.
• Harness Future-Ready Technology: Leverage digital threads and advanced manufacturing to create patient-centric, resilient organizations.
• Navigate a Shifting Regulatory Landscape:  Balance compliance with innovation to stay ahead in the age of continuous disruption.

Join Daniel for a forward-looking, thought-provoking session that will equip you with strategies to shape the future of life sciences and lead with confidence in a time of rapid change.